Skip to main content
letter
. 2019 Aug 13;2:17. Originally published 2019 Jun 3. [Version 2] doi: 10.12688/aasopenres.12972.2

Table 3. Risks associated with re-establishing Uganda Schistosoma mansoni life cycle.

Risk Inherent risk score Total
inherent
risk
Controls Residual risk score Total
risk post
control
Likelihood Impact Likelihood Impact
New isolates of S. mansoni
from the Ugandan population
might exhibit variable
praziquantel susceptibility, or
praziquantel resistance
Possible Critical 15 1)  Test new isolates for praziquantel
susceptibility in vitro and in an
animal model before use in CHI
Unlikely Critical 10
New isolates of S. mansoni
from the Ugandan population
might exhibit unexpected
virulence
Possible Critical 15 1)  Test new isolates for relative
virulence in an animal model
before use in CHI
Unlikely Critical 10
Production processes based
on GMP principles for single-
sex infectious cercariae not
established in Uganda
Possible Critical 15 1)  Development of appropriate
animal and snail facilities
2)  Training of Ugandan staff
3)  Monitoring and review by
experienced LUMC collaborators
4)  Monitoring and review by
Ugandan regulators
Rare Critical 5

Likelihood was scored as almost certain/common, 5; likely, 4; possible, 3; unlikely, 2; rare, 1. Impact was scored as critical, 5; major, 4; moderate, 3; minor, 2; insignificant 1.